ISRCTN94604465进行中（未招募）未知
The GÖTEBORG Prostate Cancer Screening 2 trial (G2): a prospective, randomized, large-scale, population-based prostate cancer screening trial using PSA followed by magnetic resonance imaging of the prostate
niversity of Gothenburg0 个研究点目标入组 17,980 人开始时间: 2017年7月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 17,980
研究概览
简要总结
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36477032/ primary and secondary outcome results (added 12/12/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •2. Age 50-60
- •3. Living in selected municipalities in Västra Götaland, Sweden
排除标准
- •Men with prior diagnosis of prostate cancer
研究者
相似试验
已完成
不适用
The Göteborg randomised population based prostate cancer screening trialProstate cancerCancerISRCTN54449243Sahlgrenska University Hospital (Sweden)20,000
已完成
2 期
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC PatientsProstate CancerNCT00654186Oncology Specialists, S.C.32
已完成
2 期
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate CancerProstate CancerNCT01615120GTx77
已完成
2 期
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer PatientsProstate CancerNCT00919035Oncology Specialists, S.C.21
进行中（未招募）
2 期
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate CancerProstate CancerNCT01990196Jonsson Comprehensive Cancer Center45